Jiangsu Aidea Pharmaceutical Co., Ltd.
SSE:688488.SS
14.04 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 335.34 | 225.356 | 134.908 | 442.706 | 244.684 | 129.694 | 81.4 | 158.505 | 32.276 |
| Short Term Investments
| 106.184 | 215.749 | 351.637 | 163.312 | 536.314 | -6.01 | -4.846 | -3.079 | 0 |
| Cash and Short Term Investments
| 441.523 | 441.105 | 486.545 | 606.018 | 780.997 | 129.694 | 81.4 | 158.505 | 32.276 |
| Net Receivables
| 183.84 | 211.479 | 145.857 | 89.678 | 127.018 | 166.072 | 150.354 | 56.308 | 77.436 |
| Inventory
| 254.972 | 184.878 | 156.151 | 114.269 | 88.061 | 65.651 | 67.807 | 69.261 | 30.734 |
| Other Current Assets
| 14.596 | 29.615 | 25.018 | 16.965 | 10.647 | 6.698 | 10.798 | 21.001 | 26.607 |
| Total Current Assets
| 894.932 | 872.381 | 802.456 | 826.931 | 1,006.724 | 368.115 | 310.36 | 305.075 | 167.053 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 434.448 | 443.539 | 447.185 | 327.303 | 255.953 | 251.384 | 256.399 | 241.36 | 178.398 |
| Goodwill
| 171.617 | 13.239 | 13.239 | 13.239 | 13.239 | 13.239 | 13.239 | 13.239 | 13.239 |
| Intangible Assets
| 180.406 | 203.723 | 181.068 | 165.136 | 146.206 | 130.016 | 104.485 | 78.45 | 74.975 |
| Goodwill and Intangible Assets
| 352.023 | 216.963 | 194.307 | 178.375 | 159.446 | 143.255 | 117.725 | 91.689 | 88.214 |
| Long Term Investments
| -36.586 | 0 | -202.829 | -105.113 | -534.371 | 9.266 | 8.74 | 7.009 | 0.832 |
| Tax Assets
| 83.854 | 54.29 | 38.67 | 19.316 | 7.882 | 8.604 | 12.263 | 12.245 | 6.657 |
| Other Non-Current Assets
| 140.893 | 0 | 375.413 | 187.802 | 551.194 | 0.357 | 3.462 | 1.858 | 2.398 |
| Total Non-Current Assets
| 974.632 | 874.184 | 852.746 | 607.684 | 440.103 | 412.866 | 398.588 | 354.161 | 276.499 |
| Total Assets
| 1,869.563 | 1,746.565 | 1,655.202 | 1,434.614 | 1,446.827 | 780.981 | 708.948 | 659.236 | 443.552 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 113.262 | 110.391 | 109.13 | 64.857 | 29.931 | 35.979 | 44.793 | 10.279 | 42.102 |
| Short Term Debt
| 220.504 | 339.405 | 149.321 | 0 | 0.023 | 132.187 | 101 | 58.202 | 40 |
| Tax Payables
| 7.932 | 2.072 | 2.409 | 1.095 | 5.585 | 7.006 | 1.756 | 1.283 | 12.11 |
| Deferred Revenue
| 0 | 6.255 | 33.117 | 21.415 | 8.368 | 24.24 | 1.756 | 21.845 | 46.77 |
| Other Current Liabilities
| 307.361 | 37.225 | 37.697 | 24.158 | 37.464 | 33.955 | 27.557 | 60.395 | 35.747 |
| Total Current Liabilities
| 649.059 | 491.568 | 331.675 | 92.542 | 73.003 | 209.127 | 175.106 | 133.418 | 129.959 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 94.253 | 72.895 | 61.496 | 1.363 | 0.351 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 49.736 | 50.285 | 56.375 | 25.05 | 7.25 | 8.297 | 2.653 | 2.462 | 2.785 |
| Deferred Tax Liabilities Non-Current
| 9.427 | 6.278 | 6.685 | 5.862 | 6.717 | 7.319 | 8.201 | 9.262 | 10.412 |
| Other Non-Current Liabilities
| -0 | 0 | 0 | 0 | -0.351 | 0 | 0.276 | 0 | 0 |
| Total Non-Current Liabilities
| 153.417 | 129.459 | 124.555 | 32.275 | 13.967 | 15.617 | 11.129 | 11.723 | 13.197 |
| Total Liabilities
| 802.476 | 621.027 | 456.23 | 124.817 | 86.97 | 224.744 | 186.235 | 145.141 | 143.156 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 420.783 | 420.783 | 420 | 420 | 420 | 360 | 160 | 160 | 134.831 |
| Retained Earnings
| -334.655 | -184.143 | -117.392 | 6.811 | 56.956 | 20.383 | -2.223 | -7.906 | 30.08 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 19.73 | 22.584 | 9.208 | 9.121 | 6.148 | 364.936 | 362.001 | 0 |
| Other Total Stockholders Equity
| 894.767 | 830.259 | 873.79 | 883.087 | 883.087 | 175.854 | 342.292 | 362.001 | 135.484 |
| Total Shareholders Equity
| 980.895 | 1,125.538 | 1,198.971 | 1,309.797 | 1,359.857 | 556.237 | 522.713 | 514.095 | 300.396 |
| Total Equity
| 1,067.087 | 1,125.538 | 1,198.971 | 1,309.797 | 1,359.857 | 556.237 | 522.713 | 514.095 | 300.396 |
| Total Liabilities & Shareholders Equity
| 1,869.563 | 1,746.565 | 1,655.202 | 1,434.614 | 1,446.827 | 780.981 | 708.948 | 659.236 | 443.552 |